ResearcherHarvard UniversityActive in the last 2 years
Derek J. Erstad
Matched on ORCID iD 0000-0002-5936-3610; OpenAlex author ID A5010601130. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 5
- Missed Opportunities for Multimodality Therapy in Resectable Pancreatic Cancer: National Disparities and Consequences for Survival. First author DOI 10.1002/jso.70408↗
- Tumor Immune Microenvironment Differences Associated With Racial Disparities in Pancreatic Cancer. Co-author DOI 10.1016/j.jss.2025.01.005↗
- Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer. Co-author DOI 10.3389/fonc.2023.1274783↗
- Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI. Co-author DOI 10.1158/1078-0432.ccr-18-1359↗
- Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. Co-author DOI 10.1242/dmm.034793↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ernest Ramsay Camp · 3 shared papers, 2023–2026 · strength 0.74
- Paper Missed Opportunities for Multimodality Therapy in Resectable Pancreatic Cancer: National Disparities and Consequences f… DOI 10.1002/jso.70408↗
- Paper Tumor Immune Microenvironment Differences Associated With Racial Disparities in Pancreatic Cancer. DOI 10.1016/j.jss.2025.01.005↗
- Paper Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer. DOI 10.3389/fonc.2023.1274783↗
- George Van Buren · 3 shared papers, 2023–2026 · strength 0.74
- Paper Missed Opportunities for Multimodality Therapy in Resectable Pancreatic Cancer: National Disparities and Consequences f… DOI 10.1002/jso.70408↗
- Paper Tumor Immune Microenvironment Differences Associated With Racial Disparities in Pancreatic Cancer. DOI 10.1016/j.jss.2025.01.005↗
- Paper Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer. DOI 10.3389/fonc.2023.1274783↗
- Mark P. Rubinstein · 2 shared papers, 2023–2025 · strength 0.41
- Zachary Gao · 2 shared papers, 2023–2025 · strength 0.41
- Eric Jay Silberfein · 1 shared paper, 2026 · strength 0.33
- John C. Johnson · 1 shared paper, 2026 · strength 0.33
- William E Fisher · 1 shared paper, 2026 · strength 0.33
- Michael D. Lanuti · 2 shared papers, 2018–2020 · strength 0.15
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. DOI 10.1242/dmm.034793↗
- Peter D. Caravan · 2 shared papers, 2018–2020 · strength 0.15
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. DOI 10.1242/dmm.034793↗
- Cristina R. Ferrone · 2 shared papers, 2018–2020 · strength 0.15
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. DOI 10.1242/dmm.034793↗
- Kenneth K. Tanabe · 2 shared papers, 2018–2020 · strength 0.15
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. DOI 10.1242/dmm.034793↗
- Nabeel M. Bardeesy · 2 shared papers, 2018–2020 · strength 0.15
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. DOI 10.1242/dmm.034793↗
- Bryan C. Fuchs · 2 shared papers, 2018–2020 · strength 0.15
- Paper Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targete… DOI 10.1158/1078-0432.ccr-18-1359↗
- Paper Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. DOI 10.1242/dmm.034793↗
- Christian T. Farrar · 1 shared paper, 2020 · strength 0.08
- Veronica Clavijo Jordan · 1 shared paper, 2020 · strength 0.08
- Theodoros P. Michelakos · 1 shared paper, 2020 · strength 0.08
- Vikram Deshpande · 1 shared paper, 2020 · strength 0.08
- Motaz Qadan · 1 shared paper, 2020 · strength 0.08
- Akhil Chawla · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.